Graham G. Walmsley's Form 4/A amendment
AmendedOlema Pharmaceuticals, Inc. (OLMA) · filed Dec 18, 2024
- Accession no.
- 0000935836-24-000764
- Filed
- Dec 18, 2024
- Trade date
- Dec 13, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Dec 17, 2024
This filing lists 2 non-derivative transactions. Open-market purchases total $4.73M. Open-market sales total $4.73M. It was filed 5 days after the trade.
This filing was later replaced by the amendment 0000935836-25-000323 (May 13, 2025). Trade tables on this site use the amended version.
This amendment replaces 0000935836-24-000763 (filed Dec 17, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Graham G. WalmsleyCIK 0001777517 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | Common Stock | SSaleDisposed | −700,761 | $6.75 | −$4,730,136.75 | 0 | Indirect | |
| Dec 13, 2024 | Common Stock | PPurchaseAcquired | +700,761 | $6.75 | +$4,730,136.75 | 700,761 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares are held by Logos Opportunities Fund I LP ("Logos Fund I"). Logos Opportunities GP, LLC ("Logos Opportunities GP") is the general partner of Logos Fund I and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- F2
The shares are held by Logos Opportunities Fund IV LP ("Logos Fund IV"). Logos Opportunities IV GP LLC ("GP IV") is the general partner of Logos Fund IV and the reporting person is a managing member of GP IV. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- F3
These securities were sold by Logos Fund I to Logos Fund IV. Logos Fund I and Logos Fund IV are under the common control of the Reporting Person.
- F4
The Form 4 filed on December 17, 2024 identified the transaction date as December 17, 2024. The transaction date was December 13, 2024.
- F5
The Form 4 filed on December 17, 2024, inadvertently reported the number of shares held by Logos Fund IV after the transaction as 1,408,875. As reported in this amended Form 4, the number of shares held by Logos Fund IV after the transaction is 700,761. The Form 4 also mistakenly reported the purchase of shares by Logos Fund IV as a disposition. The transaction was an acquisition. The transaction date was December 13, 2024.
- F6
The shares are held by Logos Opportunities Fund II LP ("Logos Fund II"). Logos Opportunities GP is the general partner of Logos Fund II and the reporting person is a managing member of Logos Opportunities GP. The Form 4 filed on December 17, 2024, incorrectly reported these shares as being held by Logos Fund IV.